Pernod Ricard resurfaces February update flagging stronger H2 India growth, rules out local IPO
Resurfacing a February 2026 disclosure, Pernod Ricard reported 4% India net-sales growth in FY26, accelerating to 8% excluding the disposed Imperial Blue brand. The maker of Royal Stag, Blenders Pride and Chivas expects stronger second-half momentum but says an India IPO is not under consideration.
The development
Pernod Ricard reported a 4 per cent rise in India net sales and expects strong H2 FY'26 momentum, while ruling out an India IPO. India growth accelerated to 8 per cent excluding disposed Imperial Blue.
The numbers
- 4 per cent
- 8 per cent
- FY'26
- July-to-June
- 6 per cent
- 3 per cent to 6 per cent
- next three years
- below 3x
- Fiscal Year 2029
- 12-13 per cent
- 1.61 billion euros
- 7.5 per cent
- 18.7 per cent
Why it matters to operators and investors
By ruling out an India IPO, Pernod Ricard indicates it will retain direct control of the market and prioritize organic premiumization and selective portfolio actions over local equity-market monetization.
What to watch next
- India organic net-sales growth and volume versus price/mix in the next half-year results.
- Margin progression after the Imperial Blue disposal and any increase in premium-and-above portfolio share.
- State excise-duty revisions, price approvals, route-to-market policy changes and election-related alcohol-sales restrictions.
- Distributor inventory levels and retail sell-through during festive and wedding demand periods.
- Competitor discounting or launch intensity from Diageo, Radico Khaitan, Allied Blenders and local premium whisky brands.
- Any change in Pernod Ricard's language on India capital investment, minority partnerships or future listing optionality.
- Prioritize distribution, on-trade activation and premium pack availability for Royal Stag, Blenders Pride and Chivas in high-growth states and urban centers.
- Redirect marketing and trade-spend freed by Imperial Blue toward higher-margin prestige-and-above brands and consumer recruitment.
- Manage the disposed-brand transition carefully to avoid distributor disruption, shelf-space losses and cannibalization by competitors.
- Fund India expansion through the parent balance sheet and local operating cash flow rather than a domestic IPO, preserving strategic control but raising the importance of return discipline.
The counter-case
The reported acceleration may be flattered by excluding the disposed Imperial Blue brand rather than reflecting broad-based organic demand. A stronger H2 outlook depends on premiumisation holding up despite inflation, state-by-state tax and distribution constraints, and intensifying competition in India’s whisky market. Ruling out an IPO also removes a potential source of locally focused capital and valuation discovery.